2135 — Raily Aesthetic Medicine International Holdings Income Statement
0.000.00%
- HK$67.41m
- HK$87.51m
- CNY199.34m
- 15
- 60
- 10
- 14
Annual income statement for Raily Aesthetic Medicine International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 165 | 188 | 165 | 189 | 199 |
Cost of Revenue | |||||
Gross Profit | 80.2 | 69.7 | 66.8 | 71.5 | 71.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 149 | 205 | 184 | 220 | 262 |
Operating Profit | 15.2 | -16.9 | -19.1 | -30.5 | -62.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.6 | -22.9 | -22.1 | -35 | -65.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.91 | -18.3 | -20.2 | -37.8 | -63.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.25 | -17.7 | -15.9 | -32.5 | -59.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.25 | -17.7 | -15.9 | -32.5 | -59.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.03 | -0.036 | -0.024 | -0.258 | -0.037 |